| Literature DB >> 26071118 |
Rui Wang1, Csaba Szabo2, Fumito Ichinose3, Asif Ahmed4, Matthew Whiteman5, Andreas Papapetropoulos6.
Abstract
Endothelial dysfunction (EDF) reflects pathophysiological changes in the phenotype and functions of endothelial cells that result from and/or contribute to a plethora of cardiovascular diseases. We review the role of hydrogen sulfide (H2S) in the pathogenesis of EDF, one of the fastest advancing research topics. Conventionally treated as an environment pollutant, H2S is also produced in endothelial cells and participates in the fine regulation of endothelial integrity and functions. Disturbed H2S bioavailability has been suggested to be a novel indicator of EDF progress and prognosis. EDF manifests in different forms in multiple pathologies, but therapeutics aimed at remedying altered H2S bioavailability may benefit all.Entities:
Keywords: cystathionine gamma-lyase; endothelium-derived hyperpolarizing factor; gasotransmitters; heme oxygenase-1; hydrogen sulfide; nitric oxide
Mesh:
Substances:
Year: 2015 PMID: 26071118 PMCID: PMC4562801 DOI: 10.1016/j.tips.2015.05.007
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN: 0165-6147 Impact factor: 14.819